Complete sequence of carbapenem-resistant Ralstonia mannitolilytica clinical isolate co-producing novel class D β-lactamase OXA-1176 and OXA-1177 in Japan
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03919-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Wataru Hayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan. Hauptthemen laut MEDLINE: Carbapenems, Escherichia coli, Ralstonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
In 2020, the Ralstonia mannitolilytica strain JARB-RN-0044 was isolated from a midstream urine sample of an elderly hospitalized patient in Japan and was highly resistant to carbapenem (i.e., imipenem, meropenem, and doripenem). Whole-genome sequencing revealed that the complete genome consists of two replicons, a 3.5-Mb chromosome and a 1.5-Mb large non-chromosomal replicon which has not been reported in R. mannitolilytica, and referred to as the “megaplasmid” in this study based on Cluster of Orthologous Group of proteins functional analysis. The strain JARB-RN-0044 harbored two novel OXA-60 and OXA-22 family class D β-lactamase genes bla OXA-1176 and bla OXA-1177 on the megaplasmid. Cloning experiments indicated that Escherichia coli recombinant clone expressing bla OXA-1176 gene showed increased minimum inhibitory concentrations (MICs) of imipenem, meropenem, and doripenem, indicating that bla OXA-1176 gene encodes carbapenemase. In contrast, E. coli recombinant clone expressing bla OXA-1177 gene showed increased MICs of piperacillin and cefazolin, but not of carbapenem. Interestingly, the 44.6 kb putative prophage region containing genes encoding phage integrase, terminase, head and tail protein was identified in the downstream region of bla OXA-1176 gene, and comparative analysis with some previously reported R. mannitolilytica isolates revealed that the prophage region was unique to strain JARB-RN-0044. The existence of a highly carbapenem-resistant R. mannitolilytica isolate may raise human health concerns in Japan, where the population is rapidly aging. IMPORTANCE Ralstonia mannitolilytica is an aerobic non-fermenting Gram-negative rod commonly found in aquatic environments and soil. The bacteria can occasionally cause severe hospital-acquired bloodstream infections in immunocompromised patients and it has been recently recognized as an emerging opportunistic human pathogen. Furthermore, some R. mannitolilytica isolates are resistant to various antimicrobial agents, including β-lactams and aminoglycosides, making antimicrobial therapy challenging and clinically problematic. However, clinical awareness of this pathogen is limited. To our knowledge, in Japan, there has been only one report of a carbapenem-resistant R. mannitolilytica clinical isolate from urine by Suzuki et al. in 2015. In this study, whole-genome sequencing analysis revealed the presence and genetic context of novel bla OXA-1176 and bla OXA-1177 genes on the 1.5 Mb megaplasmid from highly carbapenem-resistant R. mannitolilytica isolate and characterized the overall distribution of functional genes in the chromosome and megaplasmid. Our findings highlight the importance of further attention to R. mannitolilytica isolate in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
- Department of Laboratory Medicine, Mie Prefectural General Medical Center, Mie, Japan.
ORCID-Profile: Wataru Hayashi, Shizuo Kayama, Motoyuki Sugai
Förderung
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Hayashi, W., Kaiju, H., Kayama, S., Yu, L., Zuo, H., Sugawara, Y., Azuma, K., Takahashi, A., Hata, Y., & Sugai, M. (2024). Complete sequence of carbapenem-resistant Ralstonia mannitolilytica clinical isolate co-producing novel class D β-lactamase OXA-1176 and OXA-1177 in Japan. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03919-23
Vancouver
Hayashi W, Kaiju H, Kayama S, Yu L, Zuo H, Sugawara Y, et al. Complete sequence of carbapenem-resistant Ralstonia mannitolilytica clinical isolate co-producing novel class D β-lactamase OXA-1176 and OXA-1177 in Japan. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03919-23
BibTeX
@article{Hayashi2024,
author = {Hayashi, Wataru and Kaiju, Hiroyuki and Kayama, Shizuo and Yu, Liansheng and Zuo, Hui and Sugawara, Yo and Azuma, Kaoru and Takahashi, Akemi and Hata, Yuka and Sugai, Motoyuki},
title = {Complete sequence of carbapenem-resistant Ralstonia mannitolilytica clinical isolate co-producing novel class D β-lactamase OXA-1176 and OXA-1177 in Japan},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03919-23}
}
EUVIMED